Litcius/Paper detail

Enzymatic Synthesis of Chondroitin Sulfate E to Attenuate Bacteria Lipopolysaccharide-Induced Organ Damage

Jine Li, Erica Sparkenbaugh, Guowei Su, Fuming Zhang, Yongmei Xu, Ke Xia, Pen He, Sultan Nacak Baytaş, Shannon M. Pechauer, Anand Padmanabhan, Robert J. Linhardt, Rafał Pawliński, Jian Liu

2020ACS Central Science34 citationsDOIOpen Access PDF

Abstract

does not display anticoagulant activity nor react with heparin-induced thrombocytopenia antibodies isolated from patients. The successful synthesis of CS-E oligosaccharides provides structurally defined carbohydrates for advancing CS-E research and offers a potential therapeutic agent to treat life-threatening systemic inflammation.

Topics & Concepts

LipopolysaccharideChondroitin sulfateChemistryEnzymeHeparinBiochemistryGlucuronic acidPolysaccharideChondroitinBacteriaSulfationInflammationGlycosaminoglycanBiologyImmunologyGeneticsProteoglycans and glycosaminoglycans researchNeutrophil, Myeloperoxidase and Oxidative MechanismsProtease and Inhibitor Mechanisms
Enzymatic Synthesis of Chondroitin Sulfate E to Attenuate Bacteria Lipopolysaccharide-Induced Organ Damage | Litcius